Dr. Yu is currently the Associate Professor of the Institute of Chinese Medical Sciences, State Key Laboratory of Mechanism and Quality of Chinese Medicine, University of Macau. He earned his PhD degree in Biomedical Sciences from the University of Macau. His research interests focus on innovative pharmaceutical designs of Chinese medicine, the functional polymeric nanoparticles for drug delivery, and the quality consistency assessment and the quality control standard investigation of anti-inflammatory Chinese herbal medicines. He has published over 120 peer-reviewed articles in his research fields, and with an h-index of 39 (google scholar). He is serving as the editor of Phytochemical Analysis and the section editor (Nanomedicine) of Current Pharmaceutical Design.

Mr. Huy Nguyen-Thanh is a committed researcher with expertise in biotechnology and microbiology. As the presenting author of the current project on analysis of gut microbial composition through flow cytometry, he has made significant contributions to advancing flow cytometric fingerprinting for studying dynamic shifts in gut microflora. With a solid academic foundation and extensive hands-on experience in flow cytometry, Mr. Huy has successfully guided the project through critical phases. His work is fueled by a deep passion for microbiology, with a particular focus on the remarkable diversity of gut bacteria and the impacts of various substances on their populations, striving to expand scientific understanding in this vital field. Recognized for his collaborative approach, Mr. Huy is enthusiastic about connecting with fellow researchers and professionals at the conference, aiming to exchange insights, build partnerships, and explore new directions in pharmaceutical research and innovation.

N.A

Jocelin Chan – PhD, B. Pharm (1st class honours) is a research associate at the University of Sydney School of Pharmacy. She is also a practicing community pharmacist and a pharmacy owner. Jocelin’s research interests include drug-herb interactions; the use of Annona muricata (Graviola) in people living with cancer; quality use of complementary medicines, and the quality of herbal medicine products. She contributes to the development and review of monographs to resource healthcare professionals with evidence-based knowledge about drug-herb interactions. Her recent research includes evaluating the safety and tolerability of a herbal product (Annona muricata) through a clinical study in collaboration with Concord Cancer Centre, Sydney Australia.